Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BMC Bioinformatics ; 23(1): 336, 2022 Aug 13.
Article in English | MEDLINE | ID: covidwho-1993325

ABSTRACT

BACKGROUND: Single-cell RNA sequencing (scRNA-seq) technologies offer unique opportunities for exploring heterogeneous cell populations. However, in-depth single-cell transcriptomic characterization of complex tissues often requires profiling tens to hundreds of thousands of cells. Such large numbers of cells represent an important hurdle for downstream analyses, interpretation and visualization. RESULTS: We develop a framework called SuperCell to merge highly similar cells into metacells and perform standard scRNA-seq data analyses at the metacell level. Our systematic benchmarking demonstrates that metacells not only preserve but often improve the results of downstream analyses including visualization, clustering, differential expression, cell type annotation, gene correlation, imputation, RNA velocity and data integration. By capitalizing on the redundancy inherent to scRNA-seq data, metacells significantly facilitate and accelerate the construction and interpretation of single-cell atlases, as demonstrated by the integration of 1.46 million cells from COVID-19 patients in less than two hours on a standard desktop. CONCLUSIONS: SuperCell is a framework to build and analyze metacells in a way that efficiently preserves the results of scRNA-seq data analyses while significantly accelerating and facilitating them.


Subject(s)
COVID-19 , Transcriptome , Cluster Analysis , Humans , Sequence Analysis, RNA/methods , Single-Cell Analysis/methods
2.
Sci Transl Med ; 12(546)2020 06 03.
Article in English | MEDLINE | ID: covidwho-542479

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.


Subject(s)
Betacoronavirus , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Adaptive Immunity , Antigens, Viral/analysis , Betacoronavirus/genetics , Betacoronavirus/immunology , COVID-19 , Clinical Laboratory Techniques/economics , Clinical Laboratory Techniques/methods , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Costs and Cost Analysis , Cross Reactions , Humans , Immunity, Innate , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , RNA, Viral/analysis , RNA, Viral/genetics , SARS-CoV-2 , Serologic Tests/methods , Translational Research, Biomedical , United States/epidemiology , Viral Load/immunology
SELECTION OF CITATIONS
SEARCH DETAIL